SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
SOPHiA GENETICS SA (SOPH) Tops Q4 EPS by 17c
March 7, 2023 7:12 AM ESTSOPHiA GENETICS SA (NASDAQ: SOPH) reported Q4 EPS of ($0.17), $0.17 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $12.92 million.
For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.
... More